4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-001851
Options or other derivatives
- Director acquired 77,695 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Walts Alan Edmund · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-01 | Grant or award : show line 1 in the form Restricted Stock Units | +37,695 | 37,695 | D |
| 2021-04-01 | Grant or award : show line 2 in the form Stock Options (Right to Buy) | +40,000 | 40,000 | D |
Loading xslF345X03/form4-04022021_060410.xml…